This article reports on the evolving field of stem cell therapy and its impact on the management of cardiac pathology, in particular congenital heartdisease.
A combination of PRP, anti-oxidant and anti-inflammatory factors with intramyocardial injection of hydrogel has the potential to structurally and functionally improve the injured heart muscle
ABSTRACT Fifteen patients with a mean age of 57 ± 17 years underwent thoracoabdominal aortic aneurysm repair under continuous selective blood perfusion […]
